Cargando…

Prevalence of diabetic retinopathy in Brazil: a systematic review with meta-analysis

AIMS: To evaluate the prevalence of diabetic retinopathy (DR) in Brazilian adults with diabetes mellitus via a systematic review with meta-analysis. METHODS: A systematic review using PubMed, EMBASE, and Lilacs was conducted, searching for studies published up to February 2022. Random effect meta-an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chagas, Thiago Alves, dos Reis, Mateus Augusto, Leivas, Gabriel, Santos, Lucas Porto, Gossenheimer, Agnes Nogueira, Melo, Gustavo Barreto, Malerbi, Fernando Korn, Schaan, Beatriz D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979496/
https://www.ncbi.nlm.nih.gov/pubmed/36864478
http://dx.doi.org/10.1186/s13098-023-01003-2
Descripción
Sumario:AIMS: To evaluate the prevalence of diabetic retinopathy (DR) in Brazilian adults with diabetes mellitus via a systematic review with meta-analysis. METHODS: A systematic review using PubMed, EMBASE, and Lilacs was conducted, searching for studies published up to February 2022. Random effect meta-analysis was performed to estimate the DR prevalence. RESULTS: We included 72 studies (n = 29,527 individuals). Among individuals with diabetes in Brazil, DR prevalence was 36.28% (95% CI 32.66–39.97, I(2) 98%). Diabetic retinopathy prevalence was highest in patients with longer duration of diabetes and in patients from Southern Brazil. CONCLUSION: This review shows a similar prevalence of DR as compared to other low- and middle-income countries. However, the high heterogeneity observed—expected in systematic reviews of prevalence—raises concerns about the interpretation of these results, suggesting the need for multicenter studies with representative samples and standardized methodology. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-023-01003-2.